Abstract
Bone metastases represent the most common etiology of pain for patients with advanced cancer. In the United States, the most common treatment for pain caused by bone metastases in late-stage cancer cases is external beam radiotherapy in conjunction with opioids. An alternative or adjuvant to external radiotherapy is intravenous radiopharmaceutical treatment. This review explores the pros and cons of different radiopharmaceutical options, their advantages over traditional external beam radiotherapy, and the conditions for optimal efficacy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 303-313 |
| Number of pages | 11 |
| Journal | American Journal of Hospice and Palliative Medicine |
| Volume | 21 |
| Issue number | 4 |
| State | Published - Jul 2004 |
Keywords
- 117mSn-DTPA
- 153Sm-EDTMP
- 186Re-HEDP
- 32P
- Bisphosphonates
- Cancer pain treatment
- Hypercalcemia
- Orthophosphate
- Osseous metastases
- Phosphurous-32
- Radiopharmaceuticals
- Rhenium-186 hydroxyethlidene
- Samarium-153 lexidronam
- Strontium-89 chloride 89Sr
ASJC Scopus subject areas
- Medicine(all)